Morpholino

MO1-hhatla

ID
ZDB-MRPHLNO-220301-1
Name
MO1-hhatla
Previous Names
None
Target
Sequence
5' - GGCCTCCAGTGGTACACTTTATTTT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-hhatla
Phenotype
Phenotype resulting from MO1-hhatla
Phenotype Fish Figures
atrium myl7 expression increased amount, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
atrium myl7 expression increased distribution, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
bulbus arteriosus distended, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
cardiac ventricle decreased functionality, abnormal twu34Tg + MO1-hhatla Fig. 2 from Shi et al., 2020
cardiac ventricle deformed, abnormal twu34Tg + MO1-hhatla Fig. 2 from Shi et al., 2020
cardiac ventricle myh7 expression increased amount, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
cardiac ventricle myl7 expression increased amount, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
cardiac ventricle myh7 expression increased distribution, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
cardiac ventricle myl7 expression increased distribution, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
cardiac ventricle increased size, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
heart Ab4-atp2a2 labeling decreased amount, abnormal twu34Tg + MO1-hhatla Fig. 5 from Shi et al., 2020
heart atp2a2a expression decreased amount, abnormal twu34Tg + MO1-hhatla Fig. 5 from Shi et al., 2020
heart ppp3r1a expression increased amount, abnormal twu34Tg + MO1-hhatla Fig. 5 from Shi et al., 2020
heart myh7 expression increased amount, abnormal twu34Tg + MO1-hhatla Fig. 3 from Shi et al., 2020
heart nppb expression increased amount, abnormal WT + MO1-hhatla Fig. 4Fig. 5 from Shi et al., 2020
heart nppa expression increased amount, abnormal twu34Tg + MO1-hhatla Fig. 5 from Shi et al., 2020
heart myl7 expression increased amount, abnormal twu34Tg + MO1-hhatla Fig. 3 from Shi et al., 2020
heart nppb expression increased distribution, abnormal WT + MO1-hhatla Fig. 4 from Shi et al., 2020
heart morphology, abnormal twu34Tg + MO1-hhatla Fig. 5 from Shi et al., 2020
heart contraction decreased rate, abnormal twu34Tg + MO1-hhatla Fig. 2 from Shi et al., 2020
myotome disorganized, abnormal WT + MO1-hhatla Fig. 3 from Shi et al., 2020
post-vent region curved ventral, abnormal twu34Tg + MO1-hhatla Fig. 2Fig. 5 from Shi et al., 2020
post-vent region rough, abnormal twu34Tg + MO1-hhatla Fig. 2Fig. 5 from Shi et al., 2020
post-vent region shortened, abnormal twu34Tg + MO1-hhatla Fig. 2Fig. 5 from Shi et al., 2020
Phenotype of all Fish created by or utilizing MO1-hhatla
Phenotype Fish Conditions Figures
cardiac ventricle myl7 expression increased distribution, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
myotome disorganized, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
heart nppb expression increased amount, abnormal WT + MO1-hhatla control Fig. 4 from Shi et al., 2020
cardiac ventricle myh7 expression increased distribution, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
heart nppb expression increased distribution, abnormal WT + MO1-hhatla control Fig. 4 from Shi et al., 2020
cardiac ventricle myh7 expression increased amount, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
atrium myl7 expression increased distribution, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
cardiac ventricle increased size, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
cardiac ventricle myl7 expression increased amount, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
bulbus arteriosus distended, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
atrium myl7 expression increased amount, abnormal WT + MO1-hhatla control Fig. 3 from Shi et al., 2020
heart morphology, ameliorated twu34Tg + MO1-hhatla chemical treatment: tacrolimus (anhydrous) Fig. 5 from Shi et al., 2020
post-vent region curved ventral, abnormal twu34Tg + MO1-hhatla control Fig. 2Fig. 5 from Shi et al., 2020
heart myl7 expression increased amount, abnormal twu34Tg + MO1-hhatla control Fig. 3 from Shi et al., 2020
heart nppa expression increased amount, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
heart myh7 expression increased amount, abnormal twu34Tg + MO1-hhatla control Fig. 3 from Shi et al., 2020
post-vent region rough, abnormal twu34Tg + MO1-hhatla control Fig. 2Fig. 5 from Shi et al., 2020
heart nppb expression increased amount, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
heart Ab4-atp2a2 labeling decreased amount, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
heart ppp3r1a expression increased amount, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
post-vent region morphology, ameliorated twu34Tg + MO1-hhatla chemical treatment: tacrolimus (anhydrous) Fig. 5 from Shi et al., 2020
heart contraction decreased rate, abnormal twu34Tg + MO1-hhatla control Fig. 2 from Shi et al., 2020
heart morphology, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
post-vent region shortened, abnormal twu34Tg + MO1-hhatla control Fig. 2Fig. 5 from Shi et al., 2020
heart atp2a2a expression decreased amount, abnormal twu34Tg + MO1-hhatla control Fig. 5 from Shi et al., 2020
cardiac ventricle decreased functionality, abnormal twu34Tg + MO1-hhatla control Fig. 2 from Shi et al., 2020
cardiac ventricle deformed, abnormal twu34Tg + MO1-hhatla control Fig. 2 from Shi et al., 2020
Citations